Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 15, 2023 / 07:20PM GMT
Release Date Price: $17.77 (-1.71%)
Kenneth Shields
SVB Securities LLC, Research Division - Research Analyst

Good afternoon, everyone. We're now on the third day of the SVB Securities Global Biopharma Conference. I'm Ken Shields, Vice President of Equity Research, helping to cover the targeted oncology universe of companies. I'm excited to have Exelixis join us, and we have Chris Senner, Executive Vice President and Chief Financial Officer; and Peter Lamb, Executive Vice President, Scientific Strategy here. Thank you both for spending some time with us.

Christopher J. Senner
Exelixis, Inc. - Executive VP & CFO

Thanks for having us.

Kenneth Shields
SVB Securities LLC, Research Division - Research Analyst

(Operator Instructions) So just jumping right in. Perhaps, you guys can start with a brief overview of Exelixis and help refresh those in the audience that may not be as familiar with the business.

Christopher J. Senner
Exelixis, Inc. - Executive VP & CFO

Okay. So yes, thanks for having us, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot